ProfileGDS4718 / 211001_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 56% 55% 48% 54% 51% 48% 52% 55% 52% 57% 56% 47% 55% 53% 49% 51% 50% 53% 50% 45% 51% 54% 47% 52% 49% 55% 52% 52% 55% 55% 53% 48% 50% 57% 47% 50% 53% 50% 54% 47% 51% 55% 52% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.8737656
GSM549102patient 115, normal, homogenized [OPG study]5.8503955
GSM549104patient 119, normal, homogenized [OPG study]5.3765748
GSM549108patient 138, normal, homogenized [OPG study]5.7926354
GSM549119patient 077, normal, homogenized [OPG study]5.6043551
GSM549133patient 032, cancer, homogenized [OPG study]5.3567148
GSM549139patient 042, cancer, homogenized [OPG study]5.5951152
GSM549099patient 107, normal, homogenized [OPG study]5.7955
GSM549109patient 139, normal, homogenized [OPG study]5.6323252
GSM549110patient 046, normal, homogenized [OPG study]5.9045257
GSM549114patient 063, normal, homogenized [OPG study]5.7952956
GSM549122patient 082, normal, homogenized [OPG study]5.3535947
GSM549134patient 033, cancer, homogenized [OPG study]5.8119755
GSM549136patient 036, cancer, homogenized [OPG study]5.6580553
GSM549140patient 044, cancer, homogenized [OPG study]5.4461649
GSM549111patient 047, normal, homogenized [OPG study]5.5323251
GSM549113patient 057, normal, homogenized [OPG study]5.462150
GSM549132patient 031, cancer, homogenized [OPG study]5.7011753
GSM549137patient 038, cancer, homogenized [OPG study]5.4792650
GSM549142patient 047, cancer, homogenized [OPG study]5.3750445
GSM549100patient 110, normal, homogenized [OPG study]5.5750551
GSM549107patient 135, normal, homogenized [OPG study]5.740754
GSM549115patient 068, normal, homogenized [OPG study]5.2759747
GSM549116patient 072, normal, homogenized [OPG study]5.6389652
GSM549120patient 078, normal, homogenized [OPG study]5.4320149
GSM549131patient 030, cancer, homogenized [OPG study]5.7865755
GSM549118patient 074, normal, homogenized [OPG study]5.6332752
GSM549129patient 027, cancer, homogenized [OPG study]5.651252
GSM549123patient 088, normal, homogenized [OPG study]5.8331755
GSM549124patient 006, cancer, homogenized [OPG study]5.830955
GSM549126patient 015, cancer, homogenized [OPG study]5.6903853
GSM549128patient 025, cancer, homogenized [OPG study]5.3731148
GSM549103patient 117, normal, homogenized [OPG study]5.5723150
GSM549117patient 073, normal, homogenized [OPG study]5.8839357
GSM549138patient 041, cancer, homogenized [OPG study]5.3575147
GSM549141patient 045, cancer, homogenized [OPG study]5.4499350
GSM549130patient 028, cancer, homogenized [OPG study]5.6619953
GSM549101patient 111, normal, homogenized [OPG study]5.5705550
GSM549105patient 128, normal, homogenized [OPG study]5.773954
GSM549106patient 134, normal, homogenized [OPG study]5.3174247
GSM549112patient 048, normal, homogenized [OPG study]5.5888751
GSM549125patient 011, cancer, homogenized [OPG study]5.826555
GSM549127patient 024, cancer, homogenized [OPG study]5.6528452
GSM549135patient 035, cancer, homogenized [OPG study]5.3388447